Cargando…

Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion

BACKGROUNDS AND AIMS: Molecular-targeted agents are acceptable standards to treat advanced-stage hepatocellular carcinoma (HCC), however, their therapeutic benefit, ie, sorafenib, was significantly offset in case of major vessel invasion. Liver-directed concurrent chemo-radiotherapy (LD-CCRT) provid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Sojung, Lee, Hye Won, Park, Jun Yong, Kim, Seung Up, Kim, Do Young, Ahn, Sang Hoon, Han, Kwang-Hyub, Seong, Jinsil, Won, Jong Yun, Han, Dai Hoon, Kim, Beom Kyung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751588/ https://www.ncbi.nlm.nih.gov/pubmed/33365287 http://dx.doi.org/10.2147/JHC.S276528

Ejemplares similares

Overall response of both intrahepatic tumor and portal vein tumor thrombosis is a good prognostic factor for hepatocellular carcinoma patients receiving concurrent chemoradiotherapy
por: Choi, Yunseon, et al.
Publicado: (2014)

Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Kim, Jina, et al.
Publicado: (2022)

Conditional survival estimate in patients with Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy with/without concurrent radiotherapy
por: Cho, In Rae, et al.
Publicado: (2017)

Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Concurrent Chemoradiation Therapy
por: Han, Dai Hoon, et al.
Publicado: (2016)

Clinical Benefit of Hepatic Arterial Infusion Concurrent Chemoradiotherapy in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Yoon, Hong In, et al.
Publicado: (2016)

Concurrent Chemoradiotherapy Shows Long-Term Survival after Conversion from Locally Advanced to Resectable Hepatocellular Carcinoma
por: Lee, Ik Jae, et al.
Publicado: (2014)

Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinoma
por: Cha, Hyejung, et al.
Publicado: (2013)

Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy
por: Chang, Jin Won, et al.
Publicado: (2021)

Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period: A nationwide random sample study
por: Kim, Beom Kyung, et al.
Publicado: (2019)

Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals
por: Lee, Hye Won, et al.
Publicado: (2019)

Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals
por: Lee, Hye Won, et al.
Publicado: (2019)

Author Correction: Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals
por: Lee, Hye Won, et al.
Publicado: (2019)

Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase
por: Lee, Hye Won, et al.
Publicado: (2020)

Effects of Entecavir and Tenofovir on Renal Function in Patients with Hepatitis B Virus-Related Compensated and Decompensated Cirrhosis
por: Park, Jihye, et al.
Publicado: (2017)

Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
por: Kim, David Sooik, et al.
Publicado: (2019)

Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B
por: Jeon, Mi Young, et al.
Publicado: (2021)

Investigation of Oncogenic Cooperation in Simple Liver-Specific Transgenic Mouse Models Using Noninvasive In Vivo Imaging
por: Ju, Hye-Lim, et al.
Publicado: (2013)

Early α-fetoprotein response predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib
por: Lee, Sangheun, et al.
Publicado: (2015)

Transient Elastography is Superior to FIB-4 in Assessing the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
por: Kim, Seung Up, et al.
Publicado: (2016)

Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status
por: Kim, Mi Na, et al.
Publicado: (2019)

A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea
por: Lee, Jae Seung, et al.
Publicado: (2020)

Use of transient elastography to predict de novo recurrence after radiofrequency ablation for hepatocellular carcinoma
por: Lee, Sang Hoon, et al.
Publicado: (2015)

Mortality after portal vein embolization: Two case reports
por: Lee, Eung Chang, et al.
Publicado: (2017)

Daclatasvir Plus Asunaprevir for the Treatment of Patients with Hepatitis C Virus Genotype 1b Infection: Real-World Efficacy, Changes in Liver Stiffness and Fibrosis Markers, and Safety
por: Lee, Hye Won, et al.
Publicado: (2018)

Multi-Parametric Deep Learning Model for Prediction of Overall Survival after Postoperative Concurrent Chemoradiotherapy in Glioblastoma Patients
por: Yoon, Han Gyul, et al.
Publicado: (2020)

Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response
por: Lee, Hye Won, et al.
Publicado: (2016)

Predictors of Discordance in the Assessment of Skeletal Muscle Mass between Computed Tomography and Bioimpedance Analysis
por: Jo, Min Ho, et al.
Publicado: (2019)

Erratum: Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response
por: Lee, Hye Won, et al.
Publicado: (2016)

Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus
por: Sung, Min Je, et al.
Publicado: (2020)

Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis B
por: Lee, Sangheun, et al.
Publicado: (2015)

Effective Biliary Drainage and Proper Treatment Improve Outcomes of Hepatocellular Carcinoma with Obstructive Jaundice
por: Suh, Yang-Gun, et al.
Publicado: (2014)

Advanced Stage Hepatocellular Carcinoma Successfully Treated with Liver-directed Concurrent Chemoradiotherapy and Sequential Transarterial Radio-embolization
por: Noh, Minho, et al.
Publicado: (2021)

Feasibility of Sorafenib Combined with Local Radiotherapy in Advanced Hepatocellular Carcinoma
por: Cha, Jihye, et al.
Publicado: (2013)

Influence of Besifovir Dipivoxil Maleate Combined with L-Carnitine on Hepatic Steatosis in Patients with Chronic Hepatitis B
por: Jung, Yeon Woo, et al.
Publicado: (2020)

Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naïve chronic hepatitis B patients in Korea: data from the clinical practice setting in a single-center cohort
por: Ahn, Sung Soo, et al.
Publicado: (2014)

Dickkopf-1 induces angiogenesis via VEGF receptor 2 regulation independent of the Wnt signaling pathway
por: Choi, Sung Hoon, et al.
Publicado: (2017)

Clinical Outcomes of Moderately Hypofractionated Concurrent Chemoradiotherapy for Newly Diagnosed Glioblastoma
por: Kim, Nalee, et al.
Publicado: (2023)

Predictive validation of qualitative fibrosis staging in patients with chronic hepatitis B on antiviral therapy
por: Lee, Hye Won, et al.
Publicado: (2019)

Phase I dose-escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma
por: Kim, Jun Won, et al.
Publicado: (2016)

Favorable response of hepatocellular carcinoma with portal vein tumor thrombosis after radiotherapy combined with atezolizumab plus bevacizumab
por: Kim, Yong Tae, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_suusjfqem1k8mf38aui86ic915